Secondaries announced 5.25.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Aldeyra Therapeutics Inc. Symbol: ALDX Price: Last trade $5.60 Description: Re-offer $5.00 Trade Date: 5/26 Shares: 1.8 million Underwriter(s) Stifel Rating=Subscription[…]